NDC1,NDC2,NDC3,Labeler Name,Labeler Status,FDA Name,COD Status,FDA Application Number/OTC Monograph Number,Drug Category,Drug Type,Line Extension,FDA Approval Date,Market Date,Unit Type,Units Per Package Size,Therapeutic Equivalent Code,5i Indicator,Purchased Product Date,Coverage Effective Date,Drug Termination Date,Drug Reactivation Date,Date Reported to CMS
713,886,18,"COSETTE PHARMACEUTICALS, INC.",Active,Dapsone Gel 5% 90g tube,1,210178,N,1,N,3/31/2022,5/8/2023,GM,90,AB,N,,5/8/2023,,,7/17/2023
713,886,60,"COSETTE PHARMACEUTICALS, INC.",Active,Dapsone Gel 5% 60g tube,1,210178,N,1,N,3/31/2022,5/8/2023,GM,60,AB,N,,5/8/2023,,,7/17/2023
832,8304,30,"UPSHER-SMITH LABORATORIES, LLC.",Active,Isotretinoin 40mg Cpsl UD - 30 (3x10),1,76485,N,1,N,1/19/2012,6/28/2023,CAP,30,AB,N,6/28/2023,6/28/2023,,,7/18/2023
35573,463,30,BUREL PHARMACEUTICALS,Active,"Tadalafil Tablets, 20mg, 30",1,215556,N,1,N,11/4/2021,6/20/2023,TAB,30,A1,N,6/20/2023,6/20/2023,,,7/18/2023
46122,743,27,AMERISOURCE BERGEN,Active,GNP COOL AND HEAT PAIN RLF ROLL-ON 2.5OZ,9,PART348,N,2,N,3/15/2023,6/29/2023,ML,74,NR,N,,6/29/2023,,,7/18/2023
50228,192,60,"SCIEGEN PHARMACEUTICALS, INC.",Active,LACOSAMIDE TABLET 50 MG 60,1,205237,N,1,N,3/17/2022,6/30/2023,TAB,1,AB,N,,6/30/2023,,,7/20/2023
50228,193,60,"SCIEGEN PHARMACEUTICALS, INC.",Active,LACOSAMIDE TABLET 100MG 60,1,205237,N,1,N,3/17/2022,6/9/2023,TAB,1,AB,N,,6/9/2023,,,7/20/2023
50228,194,60,"SCIEGEN PHARMACEUTICALS, INC.",Active,LACOSAMIDE TABLET 150MG 60,1,205237,N,1,N,3/17/2022,6/9/2023,TAB,1,AB,N,,6/9/2023,,,7/20/2023
50228,195,60,"SCIEGEN PHARMACEUTICALS, INC.",Active,LACOSAMIDE TABLET 200MG 60,1,205237,N,1,N,3/17/2022,6/9/2023,TAB,1,AB,N,,6/9/2023,,,7/20/2023
50474,980,79,"UCB, INC.",Active,Rystiggo 140 mg/mL 2mL Vial,2,761286,S,1,N,6/26/2023,7/20/2023,ML,1,NR,Y,,7/20/2023,,,7/21/2023
51672,1409,9,"TARO PHARMACEUTICALS USA,  INC.",Active,IBUPROFEN DF BE 100MG/5ML SUS 473ML TARO,1,209204,N,1,N,6/23/2017,6/20/2023,ML,473,AB,N,6/20/2023,6/20/2023,,,7/17/2023
55150,116,1,Eugia US LLC,Active,Ampicillin & Sulbactam for Injection 1.5g - PREMIERProRx,1,90349,N,1,N,2/10/2012,9/13/2012,EA,1,AP,Y,,9/13/2012,,,7/19/2023
55150,117,1,Eugia US LLC,Active,Ampicillin & Sulbactam for Injection 3g - PREMIERProRx,1,90349,N,1,N,2/10/2012,9/13/2012,EA,1,AP,Y,,9/13/2012,,,7/19/2023
59651,381,1,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 25mg-100/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,100,AB,N,,6/14/2023,,,7/20/2023
59651,381,30,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 25mg-30/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,30,AB,N,,6/14/2023,,,7/20/2023
59651,382,1,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 50mg-100/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,100,AB,N,,6/14/2023,,,7/20/2023
59651,382,30,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 50mg-30/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,30,AB,N,,6/14/2023,,,7/20/2023
59651,382,90,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 50mg-90/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,90,AB,N,,6/14/2023,,,7/20/2023
59651,383,1,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 75mg-100/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,100,AB,N,,6/14/2023,,,7/20/2023
59651,383,30,"AUROBINDO PHARMA USA, INC.",Active,Clomipramine Hydrochloride Capsules USP 75mg-30/Bottle,1,216440,N,1,N,3/20/2023,6/14/2023,CAP,30,AB,N,,6/14/2023,,,7/20/2023
59651,456,1,"AUROBINDO PHARMA USA, INC.",Active,Carbidopa and Levodopa Tablets USP 10 mg/100 mg - 100/Bottle,1,216537,N,1,N,11/28/2022,6/14/2023,TAB,100,AB,N,,6/14/2023,,,7/20/2023
59651,457,5,"AUROBINDO PHARMA USA, INC.",Active,Carbidopa and Levodopa Tablets USP 25 mg/100 mg - 500/Bottle,1,216537,N,1,N,11/28/2022,5/4/2023,TAB,500,AB,N,,5/4/2023,,,7/20/2023
60505,405,4,APOTEX CORP.,Active,LACOSAMIDE O/SLN 10MG/ML 200ML ,1,206355,N,1,N,9/26/2022,6/14/2023,ML,200,AA,N,,6/14/2023,,,7/20/2023
60505,6095,0,APOTEX CORP.,Active,BENDAMUSTINE 25MG / 10mL,1,204230,N,1,N,6/5/2023,6/19/2023,ML,1,AP,Y,,6/19/2023,,,7/18/2023
60505,6096,0,APOTEX CORP.,Active,BENDAMUSTINE 100MG / 20mL,1,204230,N,1,N,6/5/2023,6/19/2023,ML,1,AP,Y,,6/19/2023,,,7/18/2023
60687,714,44,AMERICAN HEALTH PACKAGING,Active,Chlorhexidine Gluconate Oral Rinse,1,75561,N,1,N,1/20/2023,6/21/2023,ML,15,AT,N,,6/21/2023,,,7/18/2023
60687,714,50,AMERICAN HEALTH PACKAGING,Active,Chlorhexidine Gluconate Oral Rinse,1,75561,N,1,N,1/20/2023,6/21/2023,ML,150,AT,N,,6/21/2023,,,7/18/2023
60687,714,64,AMERICAN HEALTH PACKAGING,Active,Chlorhexidine Gluconate Oral Rinse,1,75561,N,1,N,1/20/2023,6/21/2023,ML,600,AT,N,,6/21/2023,,,7/18/2023
60687,758,11,AMERICAN HEALTH PACKAGING,Active,Lurasidone Hydrochloride Tablet,1,212244,N,1,N,5/23/2023,7/3/2023,TAB,1,AB,N,,7/3/2023,,,7/18/2023
60687,758,21,AMERICAN HEALTH PACKAGING,Active,Lurasidone Hydrochloride Tablet,1,212244,N,1,N,5/23/2023,7/3/2023,TAB,30,AB,N,,7/3/2023,,,7/18/2023
63323,579,1,"FRESENIUS KABI USA, LLC",Active,Sincalide Inj 0.005mg 5ml,3,17697,I,1,N,9/30/1990,6/20/2023,EA,2,NR,Y,,6/20/2023,,,7/20/2023
63323,579,5,"FRESENIUS KABI USA, LLC",Active,Sincalide Inj 0.005mg 5ml,3,17697,I,1,N,9/30/1990,6/20/2023,EA,2,NR,Y,,6/20/2023,,,7/20/2023
63323,810,0,"FRESENIUS KABI USA, LLC",Active,FENTANYL CITRATE 100 MCG 2ML PFS,1,212086,N,1,N,9/1/2020,6/22/2021,ML,2,AP,Y,6/27/2023,6/27/2023,,,7/20/2023
63323,810,20,"FRESENIUS KABI USA, LLC",Active,FENTANYL CITRATE 100 MCG 2ML PFS,1,212086,N,1,N,9/1/2020,6/22/2021,ML,2,AP,Y,6/27/2023,6/27/2023,,,7/20/2023
63323,930,0,"FRESENIUS KABI USA, LLC",Active,Vasopressin 20 Units 2mL SDV PF,1,213206,N,1,N,5/26/2023,6/12/2023,ML,2,AP,Y,,6/12/2023,,,7/20/2023
63323,930,1,"FRESENIUS KABI USA, LLC",Active,Vasopressin 20 Units 2mL SDV PF,1,213206,N,1,N,5/26/2023,6/12/2023,ML,2,AP,Y,,6/12/2023,,,7/20/2023
63868,102,24,"CHAIN DRUG MARKETING ASSOCIATION, INC.",Terminated,Head Congestion & Flu Severe PE (QC98740),10,PART341,N,2,N,8/3/2022,8/3/2022,TAB,24,BE,N,,8/3/2022,,,7/20/2023
63868,180,46,"CHAIN DRUG MARKETING ASSOCIATION, INC.",Terminated,Athlete's Foot Miconazole 2% (QC95253),10,PART333,N,2,N,12/19/2017,12/19/2017,GM,130,AT,N,,12/19/2017,,,7/20/2023
63868,607,1,"CHAIN DRUG MARKETING ASSOCIATION, INC.",Terminated,Original Nasal Spray (QC98844),10,PART341,N,2,N,2/1/2021,2/1/2021,ML,30,AT,N,,2/1/2021,,,7/20/2023
63868,809,8,"CHAIN DRUG MARKETING ASSOCIATION, INC.",Terminated,X/S Pain Relief Liquid Cherry Acetaminophen 500mg (QC99764) ,9,PART343,N,2,N,7/1/2023,7/1/2023,ML,237,BE,N,,7/1/2023,,,7/20/2023
65219,118,1,FRESENIUS KABI USA LLC,Active,Potassium Chloride in 5% Dextrose NACL 1.49%,1,213445,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,118,10,FRESENIUS KABI USA LLC,Active,Potassium Chloride in 5% Dextrose NACL 1.49%,1,213445,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,119,1,FRESENIUS KABI USA LLC,Active,Potassium Chloride in 5% Dextrose NACL 2.98%,1,213445,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,119,10,FRESENIUS KABI USA LLC,Active,Potassium Chloride in 5% Dextrose NACL 2.98%,1,213445,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,142,2,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 10mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,142,10,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 10mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,144,4,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 20mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,144,10,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 20mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,146,6,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 30mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,146,10,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 30mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,148,8,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 40mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,148,10,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 40mEq/1000ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,150,0,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 10mEq/500ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,500,NR,Y,,6/2/2023,,,7/20/2023
65219,150,75,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.45% Sod 10mEq/500ml,1,213523,N,1,N,3/9/2021,6/2/2023,ML,500,NR,Y,,6/2/2023,,,7/20/2023
65219,151,0,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.225% Sod 500ml,1,212348,N,1,N,7/30/2021,6/2/2023,ML,500,NR,Y,,6/2/2023,,,7/20/2023
65219,151,75,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.225% Sod 500ml,1,212348,N,1,N,7/30/2021,6/2/2023,ML,500,NR,Y,,6/2/2023,,,7/20/2023
65219,153,2,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.225% Sod 1000ml,1,212348,N,1,N,7/30/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,153,10,FRESENIUS KABI USA LLC,Active,Potassium Chl in 5% Dex & 0.225% Sod 1000ml,1,212348,N,1,N,7/30/2021,6/2/2023,ML,1000,NR,Y,,6/2/2023,,,7/20/2023
65219,387,0,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 5.5 500ML",1,215370,N,1,N,6/29/2022,6/27/2023,ML,500,AP,Y,,6/27/2023,,,7/20/2023
65219,387,2,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 5.5 1L",1,215370,N,1,N,6/29/2022,6/27/2023,ML,1000,AP,Y,,6/27/2023,,,7/20/2023
65219,387,5,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 5.5 500ML",1,215370,N,1,N,6/29/2022,6/27/2023,ML,500,AP,Y,,6/27/2023,,,7/20/2023
65219,387,10,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 5.5 1L",1,215370,N,1,N,6/29/2022,6/27/2023,ML,1000,AP,Y,,6/27/2023,,,7/20/2023
65219,389,0,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 7.4 500ML",1,215371,N,1,N,6/8/2022,6/27/2023,ML,500,AP,Y,,6/27/2023,,,7/20/2023
65219,389,2,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 7.4 1L",1,215371,N,1,N,6/8/2022,6/27/2023,ML,1000,AP,Y,,6/27/2023,,,7/20/2023
65219,389,5,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 7.4 500ML",1,215371,N,1,N,6/8/2022,6/27/2023,ML,500,AP,Y,,6/27/2023,,,7/20/2023
65219,389,10,FRESENIUS KABI USA LLC,Active,"Multiple Electrolytes T1, pH 7.4 1L",1,215371,N,1,N,6/8/2022,6/27/2023,ML,1000,AP,Y,,6/27/2023,,,7/20/2023
65219,472,5,FRESENIUS KABI USA LLC,Active,Sodium Chloride 0.9% 500mL Freeflex,1,207310,N,1,N,2/11/2014,4/2/2014,ML,500,AP,Y,6/2/2023,6/2/2023,,,7/20/2023
65219,472,20,FRESENIUS KABI USA LLC,Active,Sodium Chloride 0.9% 500mL Freeflex,1,207310,N,1,N,2/11/2014,4/2/2014,ML,500,AP,Y,6/2/2023,6/2/2023,,,7/20/2023
65862,295,99,AUROBINDO PHARMA LTD.,Active,Rosuvastatin Calcium Tablets 20 mg. - 1000/Bottle,1,79170,N,1,N,7/19/2016,9/24/2018,TAB,1000,NR,N,,9/24/2018,,,7/20/2023
66993,730,80,PRASCO LABORATORIES,Active,"Dexamethasone Tablets, USP 4 mg, 10 x 10",1,80399,N,1,N,4/20/2022,6/1/2022,TAB,100,AB,N,6/1/2022,6/1/2022,,,7/18/2023
68084,752,18,AMERICAN HEALTH PACKAGING,Active,Clopidogrel Tablet,1,76274,N,1,N,3/28/2014,4/3/2014,TAB,1,AB,N,,4/3/2014,,,7/18/2023
68084,752,19,AMERICAN HEALTH PACKAGING,Active,Clopidogrel Tablet,1,76274,N,1,N,3/28/2014,4/3/2014,TAB,20,AB,N,,4/3/2014,,,7/18/2023
69097,550,53,"CIPLA USA, INC.",Active,DEFRSROX ORAL GRANS 90MG 30X162MG CIP US,1,215026,N,1,N,2/23/2022,6/1/2023,EA,30,AB,N,,6/1/2023,,,7/21/2023
69097,560,53,"CIPLA USA, INC.",Active,DERSROX ORAL GRANS 180MG 30X324MG CIP US,1,215026,N,1,N,2/23/2022,6/1/2023,EA,30,AB,N,,6/1/2023,,,7/21/2023
69097,570,53,"CIPLA USA, INC.",Active,DERSRX ORAL GRNS 360MG 30X648MG CIPLA US,1,215026,N,1,N,2/23/2022,6/1/2023,EA,30,AB,N,,6/1/2023,,,7/21/2023
69097,981,2,"CIPLA USA, INC.",Active,Vilazodone Hydrochloride Tablets 20mg,1,208200,N,1,N,12/6/2022,6/2/2023,TAB,30,AB,N,,6/2/2023,,,7/21/2023
70069,783,1,"SOMERSET THERAPEUTICS, LLC.",Active,"Succinylcholine Chloride Injection USP, 200 mg/10 mL",1,211589,N,1,N,1/15/2020,6/21/2023,ML,10,AP,N,,6/21/2023,,,7/18/2023
70069,783,10,"SOMERSET THERAPEUTICS, LLC.",Active,"Succinylcholine Chloride Injection USP, 200 mg/10 mL",1,211589,N,1,N,1/15/2020,6/21/2023,ML,100,AP,N,,6/21/2023,,,7/18/2023
70069,783,25,"SOMERSET THERAPEUTICS, LLC.",Active,"Succinylcholine Chloride Injection USP, 200 mg/10 mL",1,211589,N,1,N,1/15/2020,6/21/2023,ML,250,AP,N,,6/21/2023,,,7/18/2023
70436,203,1,"SLATE RUN PHARMACEUTICALS, LLC",Active,Dobutamine Inj USP 250 mg / 20 mL,1,216131,N,1,N,12/21/2022,6/9/2023,EA,1,AP,Y,,6/9/2023,,,7/20/2023
70436,203,82,"SLATE RUN PHARMACEUTICALS, LLC",Active,Dobutamine Inj USP 250 mg / 20 mL,1,216131,N,1,N,12/21/2022,6/9/2023,EA,10,AP,Y,,6/9/2023,,,7/20/2023
70505,220,60,"ANALOG PHARMA, INC.",Active,NITISINONE capsules for oral use 20 mg,1,212390,N,1,N,5/2/2023,6/5/2023,CAP,1,AB,N,,6/5/2023,,,7/20/2023
71288,166,92,"MEITHEAL PHARMACEUTICALS, INC.",Active,"Pemetrexed for Injection, USP 100mg - PREMIERProRx",1,208696,N,1,N,5/25/2022,5/25/2022,EA,1,AP,Y,,5/25/2022,,,7/21/2023
71288,167,96,"MEITHEAL PHARMACEUTICALS, INC.",Active,"Pemetrexed for Injection, USP 500mg - PREMIERProRx",1,208696,N,1,N,5/25/2022,5/25/2022,EA,1,AP,Y,,5/25/2022,,,7/21/2023
71288,414,91,"MEITHEAL PHARMACEUTICALS, INC.",Active,Glycopyrrolate 0.2mg 1mL - HealthTrust - Inner NDC,1,212802,N,1,N,7/6/2021,6/22/2022,ML,1,AP,Y,,6/22/2022,,,7/21/2023
71288,414,92,"MEITHEAL PHARMACEUTICALS, INC.",Active,Glycopyrrolate 0.2mg 1mL - HealthTrust,1,212802,N,1,N,7/6/2021,6/22/2022,ML,25,AP,Y,,6/22/2022,,,7/21/2023
71288,414,93,"MEITHEAL PHARMACEUTICALS, INC.",Active,Glycopyrrolate 0.4mg 2mL - HealthTrust - Inner NDC,1,212802,N,1,N,7/6/2021,6/22/2022,ML,1,AP,Y,,6/22/2022,,,7/21/2023
71288,414,94,"MEITHEAL PHARMACEUTICALS, INC.",Active,Glycopyrrolate 0.4mg 2mL - HealthTrust,1,212802,N,1,N,7/6/2021,6/22/2022,ML,50,AP,Y,,6/22/2022,,,7/21/2023
71288,723,52,"MEITHEAL PHARMACEUTICALS, INC.",Active,"Bupivacaine HCl Injection, USP 0.25% 125mg 50mL",1,216039,N,1,N,6/23/2023,6/30/2023,ML,50,AP,Y,,6/30/2023,,,7/21/2023
71288,726,52,"MEITHEAL PHARMACEUTICALS, INC.",Active,"Bupivacaine HCl Injection, USP 0.5% 250mg per 50mL",1,216039,N,1,N,6/23/2023,6/30/2023,ML,50,AP,Y,,6/30/2023,,,7/21/2023
72485,101,5,ARMAS PHARMACEUTICALS INC.,Active,"Diphenhydramine Injection, USP 50mg/Ml",1,205723,N,1,N,8/22/2018,5/1/2019,ML,5,AP,Y,5/1/2019,9/13/2019,,,7/19/2023
72485,106,25,ARMAS PHARMACEUTICALS INC.,Active,"Levetiracetam Inj, USP 500mg/5mL x 25ct",1,211954,N,1,N,8/9/2019,2/1/2021,ML,125,AP,Y,,2/1/2021,,,7/20/2023
